Refine results:

Clear all

The PM's announcement of reforms to the immigration system for scientists is a step in the right direction. But alone it won't be enough to keep the UK as a global research leader following Brexit.

The text of our letter to Prime Minister Boris Johnson, calling on him to set out his vision for UK science as soon as possible.

2030 is the deadline for the Sustainable Development Goals. We're working with WHO and others on a global action plan.

World Health Organization logo

Opinion | 20 May 2019

5 matters of urgency for the World Health Assembly 2019 by Jeremy Farrar

Jeremy Farrar on five things that need urgent attention at this year's World Health Assembly.

In this Q&A, our Director Jeremy Farrar speaks to the National Foundation for Infectious Diseases about his career and the people who have influenced him.

illustration of influenza bacteria

Opinion | 1 March 2019

Vaccines work – for superbugs too by Ed Whiting

There's a vital set of tools to help us tackle the threat of superbugs that we're not using to their full potential. Vaccines.

A woman scientist handling test tubes at UK Biobank.

Opinion | 19 February 2019

Open access and Plan S: how Wellcome is tackling four key concerns by Robert Kiley, David Carr

There has been lots of reaction to the changes we’re making to Wellcome’s open access policy. This is how we are addressing them.

A man being vaccinated in an Ebola vaccine trial in Liberia

Opinion | 15 February 2019

This is a pivotal moment for clinical trial regulations by Beth Thompson

Globally, clinical research is governed by guidelines established almost three decades ago. And Brexit is a looming issue for UK trials.

Our investments portfolio grew to almost £25.9 billion by 30 September 2018, strengthening our ambition to spend more than £5 billion over five years on charitable activities.

Wellcome is planning to open a small office in the German capital later this year so that we can work more closely with our international partners on shared priorities.

To support the best science, the UK and EU must come to a mutually beneficial compromise, says Wellcome's Director Jeremy Farrar.

Today we’re announcing a £250m not-for-profit fund. Director Jeremy Farrar explains how the new Wellcome Leap Fund will accelerate discovery and innovation.

Pages